Page 206 - 16Neonatal Jaundice_compressed
P. 206

Appendix G





                         Clinical questions







              I.         Recognition

              Q1.        What are the factors associated with an increased risk of hyperbilirubinaemia?

                         Which factors affect the relationship between neonatal hyperbilirubinaemia and kernicterus or
                         other adverse outcomes (neurodevelopmental, auditory)?

              Q2.        What is the best method of recognising hyperbilirubinaemia?
                         What is the accuracy of various tests (clinical history and examination, urine/stool examination,
                         icterometer and transcutaneous bilirubin levels ) in recognising neonatal jaundice or
                         hyperbilirubinaemia?

              II.        Diagnosis


              Q3.        What should be included in a formal assessment of a baby with neonatal
                         hyperbilirubinaemia?

                         i)  What are the elements of a formal assessment in a baby with neonatal hyperbilirubinaemia?
                           a) Clinical examination
                           b) Total and split bilirubin
                           c) Blood tests – blood grouping, G6PD levels, haematocrit,
                           d) Urine tests
                           e) Biochemical tests (bilirubin/albumin ratio, other relevant tests)
                         ii) What is the clinical and cost-effectiveness of the tests carried out during formal assessment?
              Q4.        How useful are the following tests in predicting neonatal hyperbilirubinaemia?

                         What is the accuracy of the following tests in predicting neonatal hyperbilirubinaemia?
                         i)  Umbilical cord blood bilirubin levels
                         ii) Timed serum bilirubin levels
                         iii) Transcutaneous bilirubin levels
                         iv) End tidal CO levels Nomograms
                         v) Risk assessment
                         vi) Coombs’ test

                         What is the effectiveness (clinical & cost) of various tests in predicting hyperbilirubinaemia and
                         preventing morbidity/mortality?

              III.       Management


              Q5.        Phototherapy
                         i)  How effective is phototherapy?
                         ii) What is the best modality of giving phototherapy (clinical and cost-effectiveness)?
                           a) Conventional phototherapy (single, double or multiple phototherapy)
                           b) Sunlight
                           c) Fibreoptic phototherapy (biliblankets, bilibeds and other products)




                                                           175
   201   202   203   204   205   206   207   208   209   210   211